We appreciate the high stability and the central location here.
Lucerne offers as a growing environment for the biopharmaceutical industry as well as the high stability of a central location in Europe. Switzerland is central to the company’s European strategy as home to our European headquarters, a manufacturing.
Ans Heirman
Former Managing Director
MSD Switzerland
share